Section Arrow
NVNO.NASDAQ
- enVVeno Medical Corp
(Financial Status)
Quotes are at least 15-min delayed:2026/01/22 17:00 EST
After Hours
Last
 10.92
0 (0.00%)
Bid
10.6
Ask
11.5
High 10.92 
Low 10 
Volume
Regular Hours (Closed)
Last
 10.92
0 (0.00%)
Day High 
11.2055 
Prev. Close
10.92 
1-M High
13.78965 
Volume 
66.24K 
Bid
10.6
Ask
11.5
Day Low
9.81 
Open
10.9 
1-M Low
10.2101 
Market Cap 
7.15M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 11.9 
20-SMA 12 
50-SMA 13.26 
52-W High 196.7 
52-W Low 0.891 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-37.80/-0.45
Enterprise Value
7.85M
Balance Sheet
Book Value Per Share
44.96
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
422.11K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories108.61-12.12-10.04%15.3PE
After Hours 107.909 -0.701 -0.65%
BSXBoston Scientific Corp91.29-0.42-0.46%49.04PE
After Hours 90.9 -0.39 -0.43%
DXCMDexCom73.92+1.81+2.51%39.94PE
After Hours 73.92 0 0.00%
PACBPacific Biosciences of California2.67+0.25+10.33%-- 
After Hours 2.66 -0.01 -0.37%
MDTMedtronic plc101.34+1.05+1.05%27.2PE
After Hours 101.34 0 0.00%
Industry overview quotes are at least 15 minutes delayed
Business Description
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in asingle geographic location, the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.